ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 98 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 10.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $18,710,000 | -30.2% | 1,247,366 | -18.4% | 1.47% | -30.8% |
| Q1 2019 | $26,819,000 | +3.2% | 1,529,032 | -12.8% | 2.12% | -2.0% |
| Q4 2018 | $25,978,000 | -39.8% | 1,752,902 | 0.0% | 2.17% | -13.3% |
| Q3 2018 | $43,156,000 | +25.4% | 1,752,902 | 0.0% | 2.50% | +34.0% |
| Q2 2018 | $34,409,000 | +16.3% | 1,752,902 | +11.0% | 1.86% | +3.8% |
| Q1 2018 | $29,598,000 | – | 1,578,569 | – | 1.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |